These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11428529)

  • 1. Reliability of the time trade-off technique of utility assessment in patients with retinal disease.
    Hollands H; Lam M; Pater J; Albiani D; Brown GC; Brown M; Cruess AF; Sharma S
    Can J Ophthalmol; 2001 Jun; 36(4):202-9. PubMed ID: 11428529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility values and diabetic retinopathy.
    Brown MM; Brown GC; Sharma S; Shah G
    Am J Ophthalmol; 1999 Sep; 128(3):324-30. PubMed ID: 10511027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilities associated with diabetic retinopathy: results from a Canadian sample.
    Sharma S; Oliver-Fernandez A; Bakal J; Hollands H; Brown GC; Brown MM
    Br J Ophthalmol; 2003 Mar; 87(3):259-61. PubMed ID: 12598432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability of two methods of utility assessment in dentistry.
    Fyffe HE; Deery C; Nugent Z; Nuttall NM; Pitts NB
    Community Dent Health; 1999 Jun; 16(2):72-9. PubMed ID: 10641060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reproducibility of ophthalmic utility values.
    Brown GC; Brown MM; Sharma S; Beauchamp G; Hollands H
    Trans Am Ophthalmol Soc; 2001; 99():199-203; discussion 203-4. PubMed ID: 11797307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting visual acuity to utilities.
    Sharma S; Brown GC; Brown MM; Shah GK; Snow K; Brown H; Hollands H
    Can J Ophthalmol; 2000 Aug; 35(5):267-72. PubMed ID: 10959467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.
    Sharma S; Brown GC; Brown MM; Hollands H; Robins R; Shah GK
    Br J Ophthalmol; 2002 May; 86(5):493-6. PubMed ID: 11973240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration.
    Brown GC; Brown MM; Sharma S
    Can J Ophthalmol; 2000 Apr; 35(3):127-33. PubMed ID: 10812481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility assessment among cataract surgery patients.
    Saw SM; Gazzard G; Gomezperalta C; Au Eong KG; Seah S
    J Cataract Refract Surg; 2005 Apr; 31(4):785-91. PubMed ID: 15899457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility values and age-related macular degeneration.
    Brown GC; Sharma S; Brown MM; Kistler J
    Arch Ophthalmol; 2000 Jan; 118(1):47-51. PubMed ID: 10636413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of persistent visually disabling vitreous floaters on health status utility values.
    Zou H; Liu H; Xu X; Zhang X
    Qual Life Res; 2013 Aug; 22(6):1507-14. PubMed ID: 23054488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of comorbidities upon ocular and systemic health-related quality of life.
    Real FJ; Brown GC; Brown HC; Brown MM
    Br J Ophthalmol; 2008 Jun; 92(6):770-4. PubMed ID: 18420747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility assessment among patients with dry eye disease.
    Schiffman RM; Walt JG; Jacobsen G; Doyle JJ; Lebovics G; Sumner W
    Ophthalmology; 2003 Jul; 110(7):1412-9. PubMed ID: 12867401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project.
    Tsevat J; Dawson NV; Wu AW; Lynn J; Soukup JR; Cook EF; Vidaillet H; Phillips RS
    JAMA; 1998 Feb; 279(5):371-5. PubMed ID: 9459470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators.
    Mangione CM; Lee PP; Pitts J; Gutierrez P; Berry S; Hays RD
    Arch Ophthalmol; 1998 Nov; 116(11):1496-504. PubMed ID: 9823352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computer Time Trade-Off: a feasible and reliable alternative for the interview Time Trade-Off in rheumatoid arthritis.
    Buitinga L; Braakman-Jansen LM; Taal E; van de Laar MA
    Clin Exp Rheumatol; 2011; 29(5):783-9. PubMed ID: 21961923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and uncorrected refractive error.
    Tahhan N; Papas E; Fricke TR; Frick KD; Holden BA
    Ophthalmology; 2013 Sep; 120(9):1736-44. PubMed ID: 23664469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vision-Related Quality of Life Associated with Unilateral and Bilateral Ocular Conditions.
    Brown GC; Brown MM; Stein JD; Smiddy WE;
    Ophthalmology; 2018 Jul; 125(7):965-971. PubMed ID: 29477690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.